Picture of Ingevity logo

NGVT — Ingevity News Story

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsAdventurousMid CapHigh Flyer

Ingevity Q2 adjusted EPS beats estimates; annual outlook raised

Ingevity Q2 adjusted EPS beats estimates; annual outlook raised


Overview

  • US specialty materials firm's Q2 adjusted EPS from continuing operations beat analyst expectations

  • Q2 net sales fell 5% yr/yr, mainly due to Road Markings divestiture

  • Company completed sale of Road Markings product line and raised full-year adjusted EBITDA outlook


Outlook

  • Ingevity raises full-year 2026 net sales outlook to $1.05 bln-$1.15 bln

  • Company sees 2026 adjusted EBITDA between $380 mln and $400 mln

  • Ingevity expects 2026 diluted adjusted EPS of $5.00-$5.45


Result Drivers

  • ROAD MARKINGS DIVESTITURE - Net sales fell 5% yr/yr, mainly due to the sale of the Road Markings product line in April

  • SEGMENT GROWTH - Excluding Road Markings, sales rose 5% with growth across all three segments, driven by higher volumes, favorable mix, and pricing actions

  • ADVANCED POLYMER TECHNOLOGIES - Segment benefited from higher prices, favorable mix toward higher-value products, and competitor supply disruptions


Company press release: ID:nBw1lfhgza


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Net Sales From Contops

Slight Beat*

$314.10 mln

$312.20 mln (2 Analysts)

Q2 Adjusted EPS From Contops

Beat

$1.74

$1.33 (3 Analysts)

Q2 Net Income From Contops

$39.80 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the diversified chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Ingevity Corp is $90.00, about 27.4% above its July 29 closing price of $70.62

  • The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 14 three months ago


Reuters Recommended Reads

  • July 29 - Stepan Q2 net sales rise on surfactant, polymer growth; to cut jobs

  • July 29 - FMC Q2 adjusted EPS beats estimates, cuts FY outlook

  • July 28 - Xylem raises annual profit forecast as AI growth lifts demand for water-treatment equipment


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Ingevity

See all news